Резултати
eNauka >
Results >
An open label, randomized phase III trial evaluating the treatment (tx) effects of panitumumab (pmab) plus best supportive care (BSC) versus BSC in chemorefractory wild-type (WT) KRAS exon 2 metastatic colorectal cancer (mCRC) and in WT RAS mCRC.
| Title: | An open label, randomized phase III trial evaluating the treatment (tx) effects of panitumumab (pmab) plus best supportive care (BSC) versus BSC in chemorefractory wild-type (WT) KRAS exon 2 metastatic colorectal cancer (mCRC) and in WT RAS mCRC. | Authors  : | Kim, Tae Won; ...; (broj, koautora 16) | Issue Date: | 2016 | Publication: | JOURNAL OF CLINICAL ONCOLOGY | ISSN: | 0732-183X Journal of Clinical Oncology Search Idenfier |
Type: | Conference Paper | Collation: | vol. 34 br. 4 str. 642-642 | DOI: | 10.1200/jco.2016.34.4_suppl.642 | WoS-ID: | 000378109600618 | URI: | https://enauka.gov.rs/handle/123456789/820957 | Metadata source: | (Preuzeto iz Nasi u WoS) | M-category: | Mp. category will be shown later |
Резултати на еНаука су заштићени ауторским правима и сва права су задржана, осим ако није другачије назначено.